Decentralized clinical trials and patient-centric research software
| Date | Round | Amount |
|---|---|---|
| May 2022 | Series B Curebase, a San Francisco-based decentralized clinical trials software company, raised a $40M Series B led by Industry Ventures, with Acrew Capital, GGV Capital and Gilead Sciences participating. | $40M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.